the scientific basis for the use of immunotherapy in leukemia includes the demonstration of a relationship of rate and duration of remission and survival to immunocompetence , the demonstration of unique tumor-associated antigens on leukemia cells , and the demonstration of immune responses to these antigens which can be boosted by immunization .
C0301872
immune responses
C0003320
antigens